Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722.
Mok T, Nakagawa K, Park K, Ohe Y, Girard N, Kim HR, Wu YL, Gainor J, Lee SH, Chiu CH, Kim SW, Yang CT, Wu CL, Wu L, Lin MC, Samol J, Ichikado K, Wang M, Zhang X, Sylvester J, Li S, Forslund A, Yang JC. Mok T, et al. Among authors: forslund a. J Clin Oncol. 2024 Apr 10;42(11):1252-1264. doi: 10.1200/JCO.23.01017. Epub 2024 Jan 22. J Clin Oncol. 2024. PMID: 38252907 Free PMC article. Clinical Trial.
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control.
Stenlid R, Cerenius SY, Wen Q, Aydin BK, Manell H, Chowdhury A, Kristinsson H, Ciba I, Gjessing ES, Mörwald K, Gomahr J, Heu V, Weghuber D, Forslund A, Bergsten P. Stenlid R, et al. Among authors: forslund a. Front Endocrinol (Lausanne). 2023 Nov 1;14:1293093. doi: 10.3389/fendo.2023.1293093. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027106 Free PMC article.
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial.
Stenlid R, Cerenius SY, Manell H, Küçükemre Aydin B, Mörwald K, Gomahr J, Höghammar Mitkas M, Eriksson I, Ciba I, Geiersberger S, Thivel D, Weghuber D, Bergsten P, Forslund A. Stenlid R, et al. Among authors: forslund a. Ann Nutr Metab. 2023;79(6):522-527. doi: 10.1159/000534725. Epub 2023 Oct 26. Ann Nutr Metab. 2023. PMID: 37883939 Clinical Trial.
Championing the use of people-first language in childhood overweight and obesity to address weight bias and stigma: A joint statement from the European-Childhood-Obesity-Group (ECOG), the European-Coalition-for-People-Living-with-Obesity (ECPO), the International-Paediatric-Association (IPA), Obesity-Canada, the European-Association-for-the-Study-of-Obesity Childhood-Obesity-Task-Force (EASO-COTF), Obesity Action Coalition (OAC), The Obesity Society (TOS) and the World-Obesity-Federation (WOF).
Weghuber D, Khandpur N, Boyland E, Mazur A, Frelut ML, Forslund A, Vlachopapadopoulou E, Erhardt É, Vania A, Molnar D, Ring-Dimitriou S, Caroli M, Mooney V, Forhan M, Ramos-Salas X, Pulungan A, Holms JC, O'Malley G, Baker JL, Jastreboff AM, Baur L, Thivel D. Weghuber D, et al. Among authors: forslund a. Pediatr Obes. 2023 Jun;18(6):e13024. doi: 10.1111/ijpo.13024. Epub 2023 Apr 1. Pediatr Obes. 2023. PMID: 37002830 No abstract available.
149 results